Geneos Wealth Management’s United States Antimony UAMY Stock Holding History

Geneos Wealth Management’s Portfolio UAMY Stock Details UAMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.8K	Hold	9,892	–	–	﹤0.01%	1342
2026 Q1	$86.4K	Buy	9,892 +1,500	+18%	+$13.1K	﹤0.01%	1221
2025 Q4	$42.1K	Buy	8,392 +521	+7%	+$4.09K	﹤0.01%	1458
2025 Q3	$48.8K	Buy	+7,871	New	+$32.9K	﹤0.01%	1395
2023 Q1	–	Sell	-25,300	Closed	-$12.4K	–	2100
2022 Q4	$12.4K	Hold	25,300	–	–	﹤0.01%	1473
2022 Q3	$9K	Sell	25,300 -25,000	-50%	-$10.9K	﹤0.01%	1556
2022 Q2	$20K	Hold	50,300	–	–	﹤0.01%	1689
2022 Q1	$32K	Sell	50,300 -315	-0.6%	-$154	﹤0.01%	1578
2021 Q4	$25K	Hold	50,615	–	–	﹤0.01%	1779
2021 Q3	$44K	Buy	50,615 +25,300	+100%	+$23.3K	﹤0.01%	1552
2021 Q2	$24K	Hold	25,315	–	–	﹤0.01%	1828
2021 Q1	$23K	Hold	25,315	–	–	﹤0.01%	2015
2020 Q4	$28K	Sell	25,315 -44,685	-64%	-$18.2K	﹤0.01%	1735
2020 Q3	$21K	Hold	70,000	–	–	﹤0.01%	1640
2020 Q2	$35K	Hold	70,000	–	–	﹤0.01%	1378
2020 Q1	$24K	Hold	70,000	–	–	﹤0.01%	1437
2019 Q4	$27K	Hold	70,000	–	–	﹤0.01%	1566
2019 Q3	$38K	Sell	70,000 -18,000	-20%	-$11.7K	﹤0.01%	1317
2019 Q2	$49K	Hold	88,000	–	–	﹤0.01%	1204
2019 Q1	$41K	Hold	88,000	–	–	﹤0.01%	1240
2018 Q4	$52K	Hold	88,000	–	–	﹤0.01%	1082
2018 Q3	$75K	Sell	88,000 -122,000	-58%	-$73.5K	0.01%	990
2018 Q2	$100K	Sell	210,000 -22,000	-9%	-$7.29K	0.01%	785
2018 Q1	$58K	Sell	232,000 -36,000	-13%	-$10.7K	0.01%	944
2017 Q4	$85K	Sell	268,000 -145,000	-35%	-$38.1K	0.01%	803
2017 Q3	$119K	Sell	413,000 -47,000	-10%	-$15.5K	0.01%	648
2017 Q2	$179K	Sell	460,000 -10,000	-2%	-$4.2K	0.02%	524
2017 Q1	$232K	Hold	470,000	–	–	0.02%	443
2016 Q4	$117K	Hold	470,000	–	–	0.02%	573
2016 Q3	$211K	Hold	470,000	–	–	0.03%	435
2016 Q2	$96K	Hold	470,000	–	–	0.01%	603
2016 Q1	$112K	Buy	+470,000	New	+$116K	0.02%	554

Other funds holding UAMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Geneos Wealth Management's UAMY Position: Q2 2026 in Review

Geneos Wealth Management held its United States Antimony (UAMY) position steady in Q2 2026 at 9,892 shares worth $71.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Geneos Wealth Management first reported a position in UAMY in Q1 2016 and has held it in 32 quarters since. The position peaked at $232K in Q1 2017. 240 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

Geneos Wealth Management held 9,892 shares of United States Antimony worth $71.8K as of Q2 2026.
Geneos Wealth Management left its United States Antimony share count unchanged in Q2 2026.
United States Antimony made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1342 holding.
Geneos Wealth Management first reported a position in United States Antimony in Q1 2016 and has held it in 32 quarters since.
Geneos Wealth Management's United States Antimony position peaked at $232K in Q1 2017.
240 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.